FDA Reorganization Will Not Include John Taylor, Hamburg’s Great Actor
This article was originally published in The Pink Sheet Daily
Executive Summary
Taylor’s exit from the agency comes as commissioner awaits recommendations from a panel of senior agency officials on how to ensure the centers support Office of Regulatory Affairs’ activities without duplication.